학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 111건 | 목록 1~10
Academic Journal
Rodriguez-Fos E; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Planas-Fèlix M; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Burkert M; Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Puiggròs M; Barcelona Supercomputing Center, Joint Barcelona Supercomputing Center - Center for Genomic Regulation - Institute for Research in Biomedicine Research Program in Computational Biology, Barcelona, Spain.; Toedling J; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Thiessen N; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Berlin, Germany.; Blanc E; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Berlin, Germany.; Szymansky A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Hertwig F; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Ishaque N; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Berlin, Germany.; Beule D; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Berlin, Germany.; Torrents D; Barcelona Supercomputing Center, Joint Barcelona Supercomputing Center - Center for Genomic Regulation - Institute for Research in Biomedicine Research Program in Computational Biology, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Eggert A; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Koche RP; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Schwarz RF; Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Center for Integrated Oncology (CIO), Cancer Research Center Cologne Essen (CCCE), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; BIFOLD - Berlin Institute for the Foundations of Learning and Data, Berlin, Germany.; Haase K; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Schulte JH; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Henssen AG; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918284260106676 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-979X (Electronic) Linking ISSN: 2666979X NLM ISO Abbreviation: Cell Genom Subsets: PubMed not MEDLINE
Academic Journal
Regan JL; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.; Schumacher D; Laboratory of Molecular Tumor Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.; German Cancer Consortium (DKTK), DKFZ, 69120 Heidelberg, Germany.; Staudte S; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; German Cancer Consortium (DKTK), DKFZ, 69120 Heidelberg, Germany.; Department of Radiation Oncology and Radiotherapy, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.; Steffen A; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; Lesche R; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; Nuvisan ICB GmbH, 13353 Berlin, Germany.; Toedling J; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; Nuvisan ICB GmbH, 13353 Berlin, Germany.; Jourdan T; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; Haybaeck J; Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, 6020 Innsbruck, Austria.; Diagnostic and Research Center for Molecular Biomedicine, Institute of Pathology, Medical University of Graz, 8036 Graz, Austria.; Golob-Schwarzl N; Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, 6020 Innsbruck, Austria.; Department of Dermatology and Venereology, Medical University of Graz, 8036 Graz, Austria.; Mumberg D; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; Henderson D; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; Bayer AG, Business Development and Licensing and Open Innovation, Pharmaceuticals, 13342 Berlin, Germany.; Győrffy B; Department of Bioinformatics, Semmelweis University, 1094 Budapest, Hungary.; TTK Cancer Biomarker Research Group, Institute of Enzymology, 1117 Budapest, Hungary.; Regenbrecht CRA; Laboratory of Molecular Tumor Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.; CELLphenomics GmbH, 13125 Berlin, Germany.; Institute of Pathology, University Medical Center Göttingen, 37075 Göttingen, Germany.; Keilholz U; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.; Schäfer R; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.; Laboratory of Molecular Tumor Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.; German Cancer Consortium (DKTK), DKFZ, 69120 Heidelberg, Germany.; Lange M; Bayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.; Nuvisan ICB GmbH, 13353 Berlin, Germany.
Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Academic Journal
Schmelz K; Charité-Universitätsmedizin Berlin, Berlin, Germany.; The German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany.; The German Cancer Research Center (DKFZ), Heidelberg, Germany.; Toedling J; Charité-Universitätsmedizin Berlin, Berlin, Germany.; The German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany.; The German Cancer Research Center (DKFZ), Heidelberg, Germany.; Huska M; Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Cwikla MC; Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Kruetzfeldt LM; Charité-Universitätsmedizin Berlin, Berlin, Germany.; Proba J; Charité-Universitätsmedizin Berlin, Berlin, Germany.; Ambros PF; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, 1090, Vienna, Austria.; Ambros IM; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, 1090, Vienna, Austria.; Boral S; Charité-Universitätsmedizin Berlin, Berlin, Germany.; Lodrini M; Charité-Universitätsmedizin Berlin, Berlin, Germany.; The German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany.; The German Cancer Research Center (DKFZ), Heidelberg, Germany.; Chen CY; Charité-Universitätsmedizin Berlin, Berlin, Germany.; Experimental and Clinical Research Center (ECRC) of the Charité and Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Burkert M; Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Guergen D; Experimental Pharmacology and Oncology Berlin-Buch GmbH (EPO), Berlin, Germany.; Szymansky A; Charité-Universitätsmedizin Berlin, Berlin, Germany.; Astrahantseff K; Charité-Universitätsmedizin Berlin, Berlin, Germany.; Kuenkele A; Charité-Universitätsmedizin Berlin, Berlin, Germany.; The German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany.; The German Cancer Research Center (DKFZ), Heidelberg, Germany.; Berlin Institute of Health (BIH), Berlin, Germany.; Haase K; Charité-Universitätsmedizin Berlin, Berlin, Germany.; The German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany.; The German Cancer Research Center (DKFZ), Heidelberg, Germany.; Berlin Institute of Health (BIH), Berlin, Germany.; Fischer M; Department of Experimental Pediatric Oncology, Medical Faculty, University Children's Hospital of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Deubzer HE; Charité-Universitätsmedizin Berlin, Berlin, Germany.; The German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany.; The German Cancer Research Center (DKFZ), Heidelberg, Germany.; Experimental and Clinical Research Center (ECRC) of the Charité and Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Berlin Institute of Health (BIH), Berlin, Germany.; Hertwig F; Charité-Universitätsmedizin Berlin, Berlin, Germany.; The German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany.; The German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hundsdoerfer P; Charité-Universitätsmedizin Berlin, Berlin, Germany.; Helios Klinikum Berlin-Buch, Berlin, Germany.; Henssen AG; Charité-Universitätsmedizin Berlin, Berlin, Germany. anton.henssen@charite.de.; The German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany. anton.henssen@charite.de.; The German Cancer Research Center (DKFZ), Heidelberg, Germany. anton.henssen@charite.de.; Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany. anton.henssen@charite.de.; Experimental and Clinical Research Center (ECRC) of the Charité and Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. anton.henssen@charite.de.; Berlin Institute of Health (BIH), Berlin, Germany. anton.henssen@charite.de.; Schwarz RF; Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany. roland.schwarz@mdc-berlin.de.; BIFOLD-Berlin Institute for the Foundations of Learning and Data, Berlin, Germany. roland.schwarz@mdc-berlin.de.; Schulte JH; Charité-Universitätsmedizin Berlin, Berlin, Germany. johannes.schulte@charite.de.; The German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany. johannes.schulte@charite.de.; The German Cancer Research Center (DKFZ), Heidelberg, Germany. johannes.schulte@charite.de.; Berlin Institute of Health (BIH), Berlin, Germany. johannes.schulte@charite.de.; Eggert A; Charité-Universitätsmedizin Berlin, Berlin, Germany. angelika.eggert@charite.de.; The German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany. angelika.eggert@charite.de.; The German Cancer Research Center (DKFZ), Heidelberg, Germany. angelika.eggert@charite.de.; Berlin Institute of Health (BIH), Berlin, Germany. angelika.eggert@charite.de.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Regan JL; Bayer AG, Research & Development, Pharmaceuticals, 13342 Berlin, Germany.; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.; Schumacher D; Laboratory of Molecular Tumor Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.; German Cancer Consortium (DKTK), DKFZ, 69120 Heidelberg, Germany.; Staudte S; Bayer AG, Research & Development, Pharmaceuticals, 13342 Berlin, Germany.; German Cancer Consortium (DKTK), DKFZ, 69120 Heidelberg, Germany.; Department of Radiation Oncology and Radiotherapy, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.; Steffen A; Bayer AG, Research & Development, Pharmaceuticals, 13342 Berlin, Germany.; Lesche R; Bayer AG, Research & Development, Pharmaceuticals, 13342 Berlin, Germany.; Nuvisan ICB GmbH, 13353 Berlin, Germany.; Toedling J; Bayer AG, Research & Development, Pharmaceuticals, 13342 Berlin, Germany.; Nuvisan ICB GmbH, 13353 Berlin, Germany.; Jourdan T; Bayer AG, Research & Development, Pharmaceuticals, 13342 Berlin, Germany.; Haybaeck J; Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.; Diagnostic & Research Center for Molecular Biomedicine, Institute of Pathology, Medical University of Graz, 8036 Graz, Austria.; Mumberg D; Bayer AG, Research & Development, Pharmaceuticals, 13342 Berlin, Germany.; Henderson D; Bayer AG, Research & Development, Pharmaceuticals, 13342 Berlin, Germany.; Győrffy B; Department of Bioinformatics, Semmelweis University, 1094 Budapest, Hungary.; TTK Cancer Biomarker Research Group, Institute of Enzymology, 1117 Budapest, Hungary.; Regenbrecht CRA; Laboratory of Molecular Tumor Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.; CELLphenomics GmbH, 13125 Berlin, Germany.; Institute of Pathology, University Medical Center Göttingen, 37075 Göttingen, Germany.; Keilholz U; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.; Schäfer R; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.; Laboratory of Molecular Tumor Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.; German Cancer Consortium (DKTK), DKFZ, 69120 Heidelberg, Germany.; Lange M; Bayer AG, Research & Development, Pharmaceuticals, 13342 Berlin, Germany.; Nuvisan ICB GmbH, 13353 Berlin, Germany.
Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Toedling, J
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어